Drug:
Reaction: URTICARIA
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26555316 |
US |
||
Pruritus, Urticaria, Drug ineffective, |
||||
OMALIZUMAB, |
||||
| 2 | 26555445 |
AR |
67 | 1 |
Urticaria, Pruritus, Rash, Acne pustular, Dry skin, Epistaxis, Skin fissures, Miliaria, Perioral dermatitis, Sensitive skin, Skin burning sensation, Erythema, Lip dry, Skin disorder, Off label use, |
||||
PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, |
||||
| 3 | 26555557 |
US |
63 | 2 |
Stress cardiomyopathy, Rash pruritic, Urticaria, Condition aggravated, |
||||
NIVOLUMAB, ALPRAZOLAM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SACUBITRIL AND VALSARTAN, NITROGLYCERIN, PANTOPRAZOLE, CLOPIDOGREL, PREDNISONE, MONTELUKAST SODIUM, |
||||
| 4 | 26555562 |
EU |
||
Angioedema, Ocular hypertension, Chronic spontaneous urticaria, Condition aggravated, Urticaria, Osteoporosis, Asthenia, Myalgia, Drug intolerance, Off label use, |
||||
OMALIZUMAB, CYCLOSPORINE, |
||||
| 5 | 26556046 |
US |
2 | |
Urticaria, Dyspnoea, Fatigue, Off label use, |
||||
OMALIZUMAB, OMALIZUMAB, FLUOXETINE HYDROCHLORIDE, |
||||
| 6 | 26556461 |
EU |
1 | 2 |
Jaundice, Muscle tightness, Metabolic disorder, Sleep disorder, Vaccination site induration, Dermatitis atopic, Infection, Upper respiratory tract infection, Vaccination site oedema, Mucous stools, Feeding disorder, Faeces discoloured, Crying, Urticaria, Abdominal pain, Oral candidiasis, Vaccination site erythema, Diarrhoea, Decreased appetite, Irritability, Weight gain poor, Altered state of consciousness, Diarrhoea haemorrhagic, Immune system disorder, Syncope, Poor feeding infant, Abdominal pain upper, Lethargy, Seizure, Dermatitis allergic, Nasopharyngitis, Somnolence, Erythema, Rash, Vaccination site pain, Nervousness, Vomiting, |
||||
| 7 | 26556649 |
US |
51 | |
Urticaria, |
||||
GADOBUTROL, |
||||
| 8 | 26556688 |
CA |
63 | 2 |
Alopecia, Application site reaction, Chronic spontaneous urticaria, Depression, Dyspnoea, Dyspnoea exertional, Haemorrhage, Headache, Hepatic enzyme increased, Urticaria, Tachycardia, Insomnia, Intervertebral disc protrusion, Malaise, Middle insomnia, Muscular weakness, Pain, Paraesthesia, Primary biliary cholangitis, Pruritus, Scratch, Skin burning sensation, Skin lesion, Skin plaque, Spinal meningeal cyst, Stress, Erythema, Product dose omission issue, Drug ineffective, Incorrect dose administered, Inappropriate schedule of product administration, Wrong technique in product usage process, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, NICOTINE, NICOTINE POLACRILEX, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, |
||||
| 9 | 26556911 |
GB |
||
Chest discomfort, Urticaria, |
||||
TICAGRELOR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, FUROSEMIDE, LANSOPRAZOLE, RAMIPRIL, NITROGLYCERIN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
| 10 | 26556988 |
GB |
70 | 1 |
Chest discomfort, Urticaria, |
||||
TICAGRELOR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BISOPROLOL FUMARATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, FUROSEMIDE, NITROGLYCERIN, LANSOPRAZOLE, RAMIPRIL, |
||||
| 11 | 26557159 |
US |
22 | 2 |
Urticaria, Pruritus, Swelling, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 12 | 26557181 |
US |
2 | |
Pruritus, Urticaria, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 13 | 26557244 |
US |
64 | 2 |
Urticaria, |
||||
DUPILUMAB, |
||||
| 14 | 26557246 |
US |
29 | 2 |
Urticaria, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 15 | 26557295 |
CN |
62 | 2 |
Urticaria, Pruritus, Rash, |
||||
FRUQUINTINIB, |
||||
| 16 | 26557312 |
US |
73 | 2 |
Urticaria, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 17 | 26557440 |
US |
78 | 2 |
Urticaria, |
||||
DUPILUMAB, |
||||
| 18 | 26557443 |
US |
51 | 1 |
Urticaria, Rash, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 19 | 26557463 |
US |
2 | |
Vomiting, Diarrhoea, Urticaria, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 20 | 26557641 |
EU |
5 | 1 |
Urticaria, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METHYLPREDNISOLONE SODIUM SUCCINATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, |
||||
| 21 | 26557980 |
US |
2 | |
Urticaria, |
||||
DUPILUMAB, |
||||
| 22 | 26558487 |
US |
||
Pharyngeal swelling, Chest discomfort, Dyspnoea, Nasal congestion, Fatigue, Urticaria, Nausea, Headache, |
||||
C1 ESTERASE INHIBITOR RECOMBINANT, EPINEPHRINE, ADRENALINUM, LEVOCETIRIZINE DIHYDROCHLORIDE, PYRIDOSTIGMINE BROMIDE, FAMOTIDINE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PREDNISONE, KETOTIFEN FUMARATE, BUDESONIDE, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, VARENICLINE, VORTIOXETINE, CYCLOSPORINE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, LEVALBUTEROL TARTRATE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, MEPOLIZUMAB, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, ICATIBANT, LEVALBUTEROL HYDROCHLORIDE, LANADELUMAB-FLYO, |
||||
| 23 | 26558826 |
40 | 1 | |
Seizure, Urticaria, Blood pressure decreased, Amaurosis, |
||||
CETUXIMAB, |
||||
| 24 | 26559143 |
US |
13 | 1 |
Wheezing, Urticaria, Paraesthesia oral, Therapy cessation, Product administration error, Wrong technique in product usage process, |
||||
CETIRIZINE HYDROCHLORIDE, EPINEPHRINE, ADRENALINUM, |
||||
| 25 | 26560183 |
US |
2 | |
Urticaria, |
||||
EVOLOCUMAB, |
||||
| 26 | 26560268 |
US |
35 | 1 |
Erythema, Urticaria, |
||||
DUPILUMAB, |
||||
| 27 | 26560729 |
US |
53 | 2 |
Headache, Nausea, Diarrhoea, Erythema, Contusion, Injection site reaction, Urticaria, |
||||
PALOPEGTERIPARATIDE, PALOPEGTERIPARATIDE, CALCIUM, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, |
||||
| 28 | 26561137 |
US |
1 | |
Urticaria, |
||||
SPARSENTAN, SPARSENTAN, SPARSENTAN, |
||||
| 29 | 26565973 |
78 | 2 | |
Disease progression, Insomnia, Rash, Neutropenia, Fatigue, Urticaria, |
||||
POMALIDOMIDE, LENALIDOMIDE, |
||||
| 30 | 26569788 |
25 | 2 | |
Pruritus, Rash, Urticaria, Withdrawal syndrome, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, |
||||
| 31 | 26569901 |
|||
Rash papular, Rash erythematous, Urticaria, |
||||
TAPINAROF, |
||||
| 32 | 26550092 |
US |
71 | 2 |
Urticaria, |
||||
DUPILUMAB, FEXOFENADINE HYDROCHLORIDE, ANASTROZOLE, ANASTROZOLE TABLETS, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CALCIUM, CITALOPRAM, CITALOPRAM HYDROBROMIDE, EPINEPHRINE, GABAPENTIN, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, PANTOPRAZOLE SODIUM, ERGOCALCIFEROL, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 33 | 26550095 |
US |
13 | 2 |
Chest pain, Peripheral swelling, Condition aggravated, Musculoskeletal stiffness, Condition aggravated, Urticaria, Condition aggravated, Nausea, |
||||
DUPILUMAB, ATOMOXETINE, ATOMOXETINE, CLONIDINE, FOLIC ACID, ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, FAMOTIDINE, CARBO MORE, CIMETIDINE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, |
||||
| 34 | 26550102 |
US |
2 | |
Urticaria, |
||||
OMALIZUMAB, |
||||
| 35 | 26550158 |
US |
63 | 1 |
Urticaria, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 36 | 26550381 |
CA |
30 | 2 |
Flushing, Off label use, Swelling face, Urticaria, |
||||
RITUXIMAB, METHYLPREDNISOLONE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 37 | 26550920 |
US |
2 | |
Urticaria, Secretion discharge, Drainage, Cough, Dysphagia, Swollen tongue, Tongue discomfort, Mouth haemorrhage, Vomiting, Diarrhoea, Choking, Feeding disorder, Oral pain, Malnutrition, Ageusia, Drooling, Pruritus, Blood homocysteine increased, Cheilitis, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, EPINEPHRINE, CETIRIZINE HYDROCHLORIDE, DUPILUMAB, |
||||
| 38 | 26551253 |
EU |
72 | 1 |
Urticaria, |
||||
RAVULIZUMAB, |
||||
| 39 | 26551535 |
CA |
2 | |
Cough, Throat irritation, Urticaria, Erythema, Pruritus, |
||||
CARBOPLATIN, |
||||
| 40 | 26551772 |
EU |
||
Angioedema, Urticaria, Drug ineffective, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, COLCHICINE, COLCHICINE, COLCHICINE, |
||||
| 41 | 26551984 |
US |
57 | 1 |
Haematochezia, Anger, Feeling hot, Pain, Inflammation, Back pain, Pruritus, Nausea, Gastrointestinal sounds abnormal, Defaecation urgency, Dyschezia, Illness, Off label use, Product dose omission issue, Musculoskeletal stiffness, Urticaria, Abdominal pain, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 42 | 26551989 |
EU |
7 | 1 |
Eyelid oedema, Urticaria, Lip oedema, Conjunctival hyperaemia, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 43 | 26552298 |
US |
34 | 2 |
Petechiae, Increased tendency to bruise, Urticaria, |
||||
LEVONORGESTREL, |
||||
| 44 | 26552676 |
EU |
66 | 1 |
Anaphylactic shock, Urticaria, |
||||
ALFUZOSIN HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 45 | 26552792 |
1 | ||
Urticaria, Loss of personal independence in daily activities, Therapy interrupted, |
||||
TOBRAMYCIN, VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, |
||||
| 46 | 26552823 |
US |
2 | |
Arthritis, Urticaria, Pruritus, Product dose omission issue, Erythema, |
||||
REMIBRUTINIB, |
||||
| 47 | 26552836 |
EU |
||
Coronary artery thrombosis, Myocardial infarction, Cognitive disorder, Urticaria, Drug interaction, Drug ineffective, Off label use, Intentional product use issue, |
||||
OMALIZUMAB, OMALIZUMAB, CYCLOSPORINE, CYCLOSPORINE, LOSARTAN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, BISOPROLOL FUMARATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CITALOPRAM, CITALOPRAM HYDROBROMIDE, AMLODIPINE, FUROSEMIDE, RIVASTIGMINE, |
||||
| 48 | 26553039 |
CA |
2 | |
Angioedema, Fatigue, Swelling of eyelid, Urticaria, |
||||
TOBRAMYCIN AND DEXAMETHASONE, DIPHENHYDRAMINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, CICLESONIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 49 | 26553166 |
US |
1 | |
Urticaria, |
||||
DEGARELIX, ABIRATERONE ACETATE, PREDNISONE, |
||||
| 50 | 26553601 |
US |
66 | 1 |
Lip swelling, Urticaria, Pharyngeal swelling, |
||||
OMALIZUMAB, |
||||
| 51 | 26553940 |
EU |
54 | 2 |
Urticaria, Allergy test positive, |
||||
KETOPROFEN, KETOPROFEN, |
||||
| 52 | 26554041 |
US |
2 | |
Depression, Urticaria, Drug hypersensitivity, Anxiety, |
||||
ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, |
||||
| 53 | 26554074 |
US |
1 | |
Urticaria, |
||||
ENSIFENTRINE, |
||||
| 54 | 26554296 |
70 | 2 | |
Pruritus, Urticaria, Infusion site erythema, |
||||
| 55 | 26554336 |
EU |
44 | 2 |
Angioedema, Urticaria, Drug intolerance, Off label use, |
||||
CYCLOSPORINE, OMALIZUMAB, OMALIZUMAB, |
||||
| 56 | 26554534 |
EU |
42 | 1 |
Angioedema, Urticaria, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CYCLOSPORINE, DUPILUMAB, PREDNISONE, |
||||
| 57 | 26554755 |
US |
55 | 2 |
Urticaria, |
||||
TUCATINIB, |
||||
| 58 | 26555185 |
US |
50 | 2 |
Hypersensitivity, Urticaria, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, METHOCARBAMOL, METHOCARBAMOL TABLETS, |
||||
| 59 | 26558226 |
59 | 2 | |
Urticaria, Pruritus, Anaphylactic reaction, |
||||
GOLIMUMAB, CERTOLIZUMAB PEGOL, |
||||
| 60 | 26558666 |
48 | 2 | |
Urticaria, |
||||
USTEKINUMAB, |
||||
| 61 | 26559336 |
58 | 2 | |
Urticaria, |
||||
OFATUMUMAB, |
||||
| 62 | 26559463 |
68 | 2 | |
Rash, Urticaria, |
||||
RIBOCICLIB, PALBOCICLIB, SERTRALINE, |
||||
| 63 | 26559669 |
55 | 2 | |
Urticaria, Lip swelling, |
||||
RISANKIZUMAB-RZAA, |
||||
| 64 | 26565714 |
79 | 1 | |
Chest discomfort, Pruritus, Wheezing, Urticaria, Cough, Hypoxia, Pruritus, Injection related reaction, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 65 | 26565944 |
66 | 2 | |
Pruritus, Rash, Urticaria, Pruritus, |
||||
PEMIVIBART, |
||||
| 66 | 26569069 |
76 | 1 | |
Cough, Dyspnoea, Hypotension, Pruritus, Rash, Urticaria, |
||||
| 67 | 26569154 |
66 | 1 | |
Urticaria, Rash, |
||||
| 68 | 26548922 |
EU |
61 | 2 |
Lip swelling, Urticaria, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 69 | 26549024 |
CA |
38 | |
Asthma, Blood pressure increased, Blood urea decreased, Body mass index increased, Body temperature decreased, Dyspnoea, Forced expiratory volume decreased, Glomerular filtration rate decreased, Malaise, Middle insomnia, Obesity, Obstructive airways disorder, Oropharyngeal pain, Pain, Pneumonia, Psoriatic arthropathy, Reversible airways obstruction, Sensitivity to weather change, Swelling, Swelling face, Total lung capacity decreased, Weight decreased, Pyrexia, Urticaria, Sinusitis, Pruritus, Arthralgia, Cardiac failure congestive, Diarrhoea, Nasopharyngitis, Influenza, Cough, Anaphylactic reaction, Drug hypersensitivity, Weight increased, Respiratory disorder, Product dose omission issue, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, SECUKINUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CICLESONIDE, DIPHENHYDRAMINE HYDROCHLORIDE, CICLESONIDE, RABEPRAZOLE, RANITIDINE, SERTRALINE HYDROCHLORIDE, MONTELUKAST SODIUM, |
||||
| 70 | 26549135 |
US |
13 | 1 |
Urticaria, |
||||
DUPILUMAB, |
||||
| 71 | 26549219 |
US |
57 | 2 |
Dermatitis atopic, Urticaria, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 72 | 26549439 |
US |
37 | 2 |
Urticaria, Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 73 | 26549440 |
US |
59 | 2 |
Urticaria, Hypersensitivity, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 74 | 26549480 |
US |
34 | 1 |
Urticaria, Rash erythematous, Product use in unapproved indication, |
||||
DUPILUMAB, OMALIZUMAB, |
||||
| 75 | 26549481 |
US |
25 | 2 |
Urticaria, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 76 | 26549589 |
US |
27 | 2 |
Urticaria, Rash, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 77 | 26549626 |
US |
46 | 1 |
Urticaria, Therapeutic product effect incomplete, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DENOSUMAB, |
||||
| 78 | 26549637 |
US |
36 | 2 |
Photosensitivity reaction, Urticaria, Dyspepsia, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, ESKETAMINE HYDROCHLORIDE, |
||||
| 79 | 26549639 |
US |
2 | |
Urticaria, |
||||
DUPILUMAB, |
||||
| 80 | 26549648 |
US |
51 | 2 |
Urticaria, Drug hypersensitivity, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 81 | 26546829 |
US |
2 | |
Alopecia, Urticaria, Headache, Fatigue, Fall, Head injury, Vision blurred, Inappropriate schedule of product administration, |
||||
DUPILUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AZELASTINE, ROSUVASTATIN, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, LORATADINE, LORATADINE ORAL, AMLODIPINE BESYLATE, PANTOPRAZOLE, SERTRALINE, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE INHALATION SPRAY, TIZANIDINE, |
||||
| 82 | 26546984 |
24 | ||
Urticaria, Product dose omission issue, Insurance issue, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 83 | 26547040 |
EU |
||
Renal failure, Urticaria, Pruritus, Drug ineffective, |
||||
OMALIZUMAB, CYCLOSPORINE, DUPILUMAB, |
||||
| 84 | 26547066 |
US |
2 | |
Urticaria, |
||||
DUPILUMAB, PREDNISONE, FEXOFENADINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, HYDROXYZINE, |
||||
| 85 | 26547237 |
US |
||
Pruritus, Urticaria, |
||||
ESTRADIOL, |
||||
| 86 | 26547254 |
US |
2 | |
Urticaria, Rash, |
||||
DUPILUMAB, MELATONIN, |
||||
| 87 | 26547377 |
US |
56 | 2 |
Urticaria, |
||||
DUPILUMAB, |
||||
| 88 | 26547412 |
US |
62 | 2 |
Dermatitis atopic, Urticaria, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 89 | 26547558 |
US |
1 | |
Urticaria, |
||||
DUPILUMAB, |
||||
| 90 | 26547581 |
US |
2 | |
Urticaria, Skin irritation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 91 | 26548053 |
US |
11 | 2 |
Urticaria, Pruritus, Injection site pain, |
||||
DUPILUMAB, |
||||
| 92 | 26548531 |
US |
2 | |
Sleep disorder due to a general medical condition, Rash, Urticaria, |
||||
DUPILUMAB, |
||||
| 93 | 26548612 |
US |
2 | |
Dyspnoea, Urticaria, Product use in unapproved indication, |
||||
DUPILUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, CITALOPRAM, CITALOPRAM HYDROBROMIDE, HYDROXYZINE, ALBUTEROL SULFATE, ALBUTEROL, ALPRAZOLAM, ZOLPIDEM TARTRATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, CELECOXIB, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FOLIC ACID, METHYLPREDNISOLONE, MONTELUKAST, NICOTINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISONE, PREGABALIN, |
||||
| 94 | 26558429 |
67 | 2 | |
Injection site reaction, Urticaria, Drug hypersensitivity, |
||||
TIRZEPATIDE, FLUOXETINE HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, ROSUVASTATIN, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 95 | 26542295 |
CA |
38 | |
Abdominal distension, Abdominal tenderness, Chest discomfort, Disturbance in attention, Dry skin, Dry throat, Dysphonia, Gastroenteritis viral, Hypertension, Lymph node palpable, Musculoskeletal pain, Nasal discharge discolouration, Oral pain, Oropharyngeal pain, Restless legs syndrome, Sinus pain, Skin exfoliation, Swelling, Erythema, Fatigue, Injection site swelling, Lymphadenopathy, Myalgia, Pruritus, Upper respiratory tract infection, Urticaria, Drug hypersensitivity, Drug ineffective, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PENICILLIN G SODIUM, DIPHENHYDRAMINE HYDROCHLORIDE, LORATADINE, LORATADINE TABLET, MONTELUKAST SODIUM, |
||||
| 96 | 26542443 |
US |
2 | |
Urticaria, |
||||
BEMPEDOIC ACID, |
||||
| 97 | 26542481 |
US |
||
Pruritus, Urticaria, |
||||
BEMPEDOIC ACID, |
||||
| 98 | 26542492 |
EU |
44 | 2 |
Angioedema, Urticaria, Drug intolerance, |
||||
OMALIZUMAB, OMALIZUMAB, CYCLOSPORINE, |
||||
| 99 | 26542826 |
US |
1 | |
Therapy change, Urticaria, Back pain, Adverse reaction, Flushing, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
| 100 | 26543010 |
NZ |
38 | 2 |
Stillbirth, Maternal exposure during pregnancy, Urticaria, Flushing, |
||||
IOHEXOL, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28